EORTC-20971-22997-LYMG-ROG - 22997

A Phase III randomized study on low-dose total body irradiation and involved field radiotherapy in patients with localized, stages I and II, low grade non-Hodgkin's lymphoma
Study documentation
Trial StatusClosed for recruitment
DatesDate of activation: 25-Jan-01
Closed on : 02-Mar-09
Data management at EORTCFull
Phase3
Randomized trialYes
TypeHemato-malign
Targeted Sample size344
Number of steps1
Drug
Study StaffMarten Beijert (Study Coordinator) - University Medical Center Groningen, Groningen
Pierre Richaud (Study Coordinator) - Institut Bergonie, Bordeaux
Catherine Fortpied (Statistician) - EORTC Headquarters, Brussels
Livia Giurgea (Data Manager) - EORTC Headquarters, Brussels
Sarah Nuyens (Project Manager) - EORTC Headquarters, Brussels, sarah.nuyens( at )eortc.be, +32 27741089
Type of cancerNon Hodgkins Lymphoma
Participating GroupsEORTC Lymphoma Group(Coordinating Group)
EORTC Radiation Oncology Group
Protocol summaryCancer.gov (PDQ)
ClinicalTrials.gov
NCT numberNCT00014326
EudraCT